Skip to main content
Alan Krensky, MD, Pediatric Nephrology, Chicago, IL

AlanMichaelKrenskyMD

Pediatric Nephrology Chicago, IL

LCMB, CCR, NCI, NIH

Dr. Krensky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Krensky's full profile

Already have an account?

  • Office

    420 E Superior St
    Bldg 12F
    Chicago, IL 60611
    Phone+1 301-728-2151

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Nephrology, 1981 - 1983
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Nephrology, 1980 - 1981
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1979 - 1980
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1977 - 1978
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1977
  • University of Pennsylvania
    University of PennsylvaniaB.A, Biology, Summa Cum Laude, 1969 - 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1984 - 2013
  • American Board of Pediatrics Pediatrics
  • 1981 Massachusetts License Registration; 1982 American Board of Pediatrics; 1984 California Medical License

Awards, Honors, & Recognition

  • Krensky (named) Clinical Fellowship Endowment Lucile Salter Packard Children’s Hospital and Stanford University, 2007
  • First Annual Zane Staebler Memorial Lecture David Geffen School of Medicine, UCLA, 2006
  • Faculty Mentor Award Immunology Program, Stanford University, 2006
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • A human class II derived peptide antagonizes phosphatidyl 3-kinase to block IL-2 signaling.  
    Boytim, M. L., Lilly, P., Drouvalakis, K., Lyu, S.-C., Jung, R., Krensky, A. M., Clayberger, C, J. Clin. Invest
  • Identification of epitopes of Mycobacterium tuberculosis 16kDa protein recognized by human leukocyte antigen A*0201 CD8+ T lymphocytes.  
    Caccamo N, Milano S, Di Sano C, Cigna D, Ivanyi J, Krensky AM, Dieli F, Salerno A, J. Infec. Dis
  • DQ 65-79, a peptide derived from HLA Class II, induces IkB expression.  
    Jiang Y, Chen D, Lyu S-C, Ling X, Krensky AM, Clayberger C, J. Immunol
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Other

  • Tail positions of Cercopithecus aethiops. 
    Bernstein PW, Smith WJ, Krensky A, Rosene K, Z. Tierpsychol
  • HLA antigens in mucocutaneous lymph node syndrome in New England. 
    Krensky AM, Berenberg W, Shanley K, Yunis EJ, Pediatrics
  • Elevated nephrogenous cyclic adenosine monophosphate to monitor early renal osteodystrophy. 
    Krensky AM, Harmon WE, Ingelfinger JR, Kirkpatrick JR, Grupe WE, Clin. Nephrology
  • Join now to see all

Grant Support

  • Regulation Of Rantes Expression In T LymphocytesNational Cancer Institute2010–2011
  • Function Of GranulysinNational Cancer Institute2010–2011
  • Regulation Of Rantes Expression In T LymphocytesDivision Of Basic Sciences - Nci2009
  • Function Of GranulysinDivision Of Basic Sciences - Nci2009
  • Function Of GranulysinNational Cancer Institute2008
  • Regulation Of Expression And Mechanism Of Action Of Granulysin And RantesNational Cancer Institute2007
  • Antigens In Ctl-Mediated Transplant RejectionNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
  • Granulysin: A Novel Cytolytic MoleculeNational Institute Of Allergy And Infectious Diseases2002–2005
  • Granulysin: A Novel Cytolytic MoleculeNational Institute Of Allergy And Infectious Diseases2001
  • Antigens In CTL Mediated Transplant RejectionNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001
  • HLA Derived Peptides As Novel ImmunosuppressivesNational Institute Of Allergy And Infectious Diseases1999–2000
  • Granulysin, A Novel Cytolytic MoleculeNational Institute Of Allergy And Infectious Diseases1998–2000
  • Mechanism Of Action Of HLA Class I PeptidesNational Institute Of Allergy And Infectious Diseases1997–2000
  • HLA Drived Peptides As Novel ImmunosuppressivesNational Institute Of Allergy And Infectious Diseases1997–1998
  • Tumor Specific Cytotoxic T-Lymphocytes In Bone Marrow TransplantationNational Cancer Institute1996
  • Hla-Derived Peptides As Novel ImmunosuppressivesNational Institute Of Allergy And Infectious Diseases1993–1996
  • Antigens In CTL Mediated Transplant RejectionNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1996
  • Cellular And Molecular Studies Of HLA RecognitionNational Cancer Institute1988–1992
  • Antigens In CTL Mediated Transplant RejectionNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985